Mangalam Drugs & Organics Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 4,475.61 million compared to INR 3,799.77 million a year ago. Revenue was INR 4,511.58 million compared to INR 3,846.98 million a year ago. Net income was INR 196.58 million compared to INR 279.71 million a year ago. Basic earnings per share from continuing operations was INR 12.42 compared to INR 17.67 a year ago. Diluted earnings per share from continuing operations was INR 12.42 compared to INR 17.67 a year ago.